Evaluation of recombinant cytochromes P450 activity in metabolic pathways

Drug Metabolism and Disposition

Volumn 31, Issue 1, 2003, Pages 145-146

  Rochat, Bertrand ^a   Gillam, Elizabeth M J ^b   Lennard, Martin S ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CYTOCHROME P450; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; RECOMBINANT CYTOCHROME P450; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TAMOXIFEN; UNCLASSIFIED DRUG;

DNA ADDUCT; DRUG CLEARANCE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RESISTANCE; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME KINETICS; HYDROXYLATION; LETTER; LIVER MICROSOME; MICHAELIS CONSTANT; MICROSOME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG EVALUATION, PRECLINICAL; ENZYME ACTIVATION; HUMANS; TAMOXIFEN;

EID: 0038347112     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.1.145     Document Type: Letter

References (0)